Guangqiang Meng

Rituximab-containing immuno-chemotherapy regimens are effective for the elimination of EBV for EBV-HLH with only and mainly B lymphocytes of EBV infection

Guangqiang Meng, Jingshi Wang, Yini Wang et al. · International Immunopharmacology · 2021 · 36 citations

Life Sciences, Immunology, Oncology +12

The DEP regimen is superior to the HLH-1994 regimen as first-line therapy for lymphoma-associated haemophagocytic lymphohistiocytosis

Guangqiang Meng, Yini Wang, Jingshi Wang et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 19 citations

Medicine, Hematology, Oncology +10

Ruxolitinib treatment for SR-aGVHD in patients with EBV-HLH undergoing allo-HSCT

Guangqiang Meng, Jingshi Wang, Xinkai Wang et al. · Annals of Hematology · 2019 · 16 citations

Life Sciences, Immunology, Oncology +3

Immune <scp>checkpoint‐related</scp> gene polymorphisms are associated with acute myeloid leukemia

Yuyan Wu, Mingying Li, Guangqiang Meng et al. · Cancer Medicine · 2023 · 12 citations · Full text

Medicine, Genetics, Oncology +17